Pharvaris N.V.
(PHVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 369,995 | 399,909 | 423,430 | 172,358 | 195,387 |
| Receivables | 1,735 | 915 | 1,125 | 336 | 365 |
| Income taxes - deferred | N/A | N/A | N/A | 23 | N/A |
| Other current assets | 6,377 | 8,244 | 6,040 | 10,723 | 10,340 |
| TOTAL | $378,107 | $409,068 | $430,595 | $183,440 | $206,092 |
| Non-Current Assets | |||||
| PPE Net | 278 | 258 | 242 | 231 | 240 |
| Other Non-Current Assets | 518 | 629 | 670 | 639 | 565 |
| TOTAL | $796 | $887 | $913 | $869 | $805 |
| Total Assets | $378,903 | $409,955 | $431,507 | $184,309 | $206,896 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,197 | 6,035 | 3,149 | 4,826 | 5,755 |
| Accrued Expenses | 17,077 | 13,191 | 11,978 | 12,501 | 11,167 |
| TOTAL | $20,497 | $19,930 | $15,804 | $17,539 | $17,340 |
| Non-Current Liabilities | |||||
| TOTAL | $47 | $76 | $47 | $105 | $120 |
| Total Liabilities | $20,544 | $20,006 | $15,851 | $17,644 | $17,460 |
| Shareholders' Equity | |||||
| Common Shares | 6,979 | 7,012 | 6,791 | 5,353 | 5,342 |
| Retained earnings | -349,742 | -319,215 | -287,804 | -253,176 | -227,745 |
| Other shareholders' equity | 34,469 | 32,446 | 30,175 | 28,507 | 26,457 |
| TOTAL | $358,359 | $389,949 | $415,656 | $166,665 | $189,436 |
| Total Liabilities And Equity | $378,903 | $409,955 | $431,507 | $184,309 | $206,896 |